Analysis of Changes in Neurological Status and Vital Signs of Acute Stroke Patients Who Receive Mannitol Therapy at Medan City Hospital

Oct 13, 2025 by talynt.org 143 views

Analysis of Changes in Neurological Status and Vital Signs of Acute Stroke Patients Who Receive Mannitol Therapy at Medan City Hospital

Introduction

Hemorrhagic stroke is a serious medical condition that occurs when blood vessels in the brain rupture, causing bleeding in the brain tissue or on the surface of the brain. This condition can lead to complications such as cerebral edema and increased intracranial pressure, which are significant challenges for intensive stroke care units. One of the interventions used to reduce cerebral edema and overcome increased intracranial pressure is mannitol therapy. This study aims to analyze changes in neurological status and vital signs in acute phase patients who undergo mannitol therapy at Medan City Hospital.

Background

Mannitol therapy has been used for decades to reduce cerebral edema and overcome increased intracranial pressure. However, the effectiveness of this therapy in acute phase stroke patients is still unclear. Research has shown that mannitol works as an osmotic diuretic, which functions to attract fluids from brain tissue into blood vessels, reducing intracranial pressure. This is crucial in the management of stroke patients, as high levels of intracranial pressure can cause permanent damage to brain tissue.

Methodology

This study used a descriptive cohort design involving 34 respondents who underwent mannitol therapy at Medan City Hospital. The respondents were selected using purposive sampling techniques. Data analysis was carried out using a univariate approach. The neurological status of the patients was measured using the Coma Glasgow (GCS) scale and cranial nerve evaluation. Vital signs were also monitored to assess the effectiveness of mannitol therapy.

Results

The results of this study showed a significant improvement in the patient's neurological status after receiving mannitol therapy. The level of consciousness, as measured by the GCS scale, improved significantly after more than 24 hours of therapy. Cranial nerve evaluation also showed improvements in the patient's awareness level, with some patients experiencing improvements in facial muscles (cranial nerve VII) after the third day of treatment. Vital signs also showed improvement after receiving mannitol therapy, with some patients experiencing hypertension on the third day of treatment.

Discussion

The results of this study indicate that mannitol therapy is effective in reducing cerebral edema and overcoming increased intracranial pressure in acute phase stroke patients. The improvement in neurological status and vital signs suggests that cerebral blood flow (CBF) and cerebral pressure pressure (CPP) have improved, and nerve cells affected by the stroke have been improved. Further analysis of the effects of mannitol therapy also shows that mannitol works as an osmotic diuretic, which functions to attract fluids from brain tissue into blood vessels, reducing intracranial pressure.

Conclusion

This study provides a clear picture of the efficacy of mannitol therapy in dealing with acute phase stroke patients. With significant improvements to neurological status and vital signs, this therapy is one of the therapy choices that need to be considered by medical personnel in handling stroke patients. This study also opens opportunities for further research to optimize the treatment and care of stroke patients in the future.

Recommendations

Based on the results of this study, the following recommendations are made:

Mannitol therapy should be considered as a treatment option for acute phase stroke patients.
Strict monitoring of neurological status and vital signs is essential in the intensive care unit.
Further research is needed to optimize the treatment and care of stroke patients.
The use of mannitol therapy should be evaluated in combination with other treatments to improve outcomes for stroke patients.

Limitations

This study has several limitations, including:

The small sample size of 34 respondents.
The use of a descriptive cohort design, which may not be generalizable to other populations.
The lack of control group, which makes it difficult to determine the effectiveness of mannitol therapy.

Future Research Directions

Future research should focus on:

Evaluating the effectiveness of mannitol therapy in combination with other treatments.
Investigating the optimal dosage and duration of mannitol therapy.
Conducting a randomized controlled trial to determine the effectiveness of mannitol therapy in acute phase stroke patients.

Conclusion

In conclusion, this study provides a clear picture of the efficacy of mannitol therapy in dealing with acute phase stroke patients. With significant improvements to neurological status and vital signs, this therapy is one of the therapy choices that need to be considered by medical personnel in handling stroke patients. This study also opens opportunities for further research to optimize the treatment and care of stroke patients in the future.
Frequently Asked Questions (FAQs) About Mannitol Therapy in Acute Stroke Patients

Q: What is mannitol therapy?

A: Mannitol therapy is a treatment used to reduce cerebral edema and overcome increased intracranial pressure in acute stroke patients. It works as an osmotic diuretic, which functions to attract fluids from brain tissue into blood vessels, reducing intracranial pressure.

Q: How does mannitol therapy work?

A: Mannitol therapy works by increasing the osmotic pressure in the blood vessels, which helps to draw fluids from the brain tissue into the blood vessels. This reduces the amount of fluid in the brain and decreases intracranial pressure.

Q: What are the benefits of mannitol therapy in acute stroke patients?

A: The benefits of mannitol therapy in acute stroke patients include:

Reduced cerebral edema
Decreased intracranial pressure
Improved neurological status
Improved vital signs

Q: What are the potential side effects of mannitol therapy?

A: The potential side effects of mannitol therapy include:

Hypertension
Dehydration
Electrolyte imbalance
Renal failure

Q: Who should receive mannitol therapy?

A: Mannitol therapy should be considered for acute stroke patients who have:

Cerebral edema
Increased intracranial pressure
Poor neurological status
Poor vital signs

Q: How is mannitol therapy administered?

A: Mannitol therapy is typically administered intravenously, with the dose and frequency determined by the treating physician.

Q: What are the potential complications of mannitol therapy?

A: The potential complications of mannitol therapy include:

Cerebral hemorrhage
Cerebral infarction
Renal failure
Electrolyte imbalance

Q: Can mannitol therapy be used in combination with other treatments?

A: Yes, mannitol therapy can be used in combination with other treatments, such as anticoagulants, antiplatelet agents, and corticosteroids.

Q: What are the potential interactions between mannitol therapy and other medications?

A: The potential interactions between mannitol therapy and other medications include:

Increased risk of bleeding with anticoagulants and antiplatelet agents
Increased risk of electrolyte imbalance with corticosteroids
Increased risk of renal failure with certain medications

Q: How should mannitol therapy be monitored?

A: Mannitol therapy should be monitored closely, with regular checks of:

Neurological status
Vital signs
Electrolyte levels
Renal function

Q: What are the potential outcomes of mannitol therapy in acute stroke patients?

A: The potential outcomes of mannitol therapy in acute stroke patients include:

Improved neurological status
Improved vital signs
Reduced cerebral edema
Decreased intracranial pressure

Q: Can mannitol therapy be used in patients with a history of kidney disease?

A: Mannitol therapy should be used with caution in patients with a history of kidney disease, as it may exacerbate renal failure.

Q: Can mannitol therapy be used in patients with a history of electrolyte imbalance?

A: Mannitol therapy should be used with caution in patients with a history of electrolyte imbalance, as it may exacerbate the imbalance.

Q: What are the potential long-term effects of mannitol therapy in acute stroke patients?

A: The potential long-term effects of mannitol therapy in acute stroke patients include:

Improved neurological function
Improved quality of life
Reduced risk of stroke recurrence

Q: Can mannitol therapy be used in patients with a history of stroke?

A: Mannitol therapy can be used in patients with a history of stroke, but it should be used with caution and under close monitoring.

Q: What are the potential risks of mannitol therapy in patients with a history of stroke?

A: The potential risks of mannitol therapy in patients with a history of stroke include:

Increased risk of cerebral hemorrhage
Increased risk of cerebral infarction
Increased risk of renal failure
Increased risk of electrolyte imbalance